About this trial
Patient Profile
Any solid Tumour with a Somatic HER2 or EGFR Exon 18 Mutation
Where’s this trial being run?
Cork University Hospital, St Vincents University Hospital, University Hospital Waterford, and Mater Misericordiae University Hospital
Can I join this study / trial?
The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.
Why not Print this page and bring it with you. It will help your doctor and research team advise you.
Print this pageFor more detailed information
Click HereQuestions?
Here’s a list of questions you may have for your doctor or local cancer research team.
QuestionsSummary Data
| Name: | PUMA-NER 5201/SUMMIT |
|---|---|
| Number: | CTRIAL-IE 19-22 |
| Full Title: | An Open-label, Phase 2 Study of Neratinib in Patients With Solid Tumors With Somatic Human Epidermal Growth Factor Receptor (EGFR, HER2, HER3) Mutations or EGFR Gene Amplification (SUMMIT) |
| Principal Investigator: | John Crown |
|---|---|
| Type: | Industry Sponsored |
| Sponsor: | Puma Biotechnology Inc. |
| Recruitment Started: |
Global: Ireland: |
| Global Recruitment Target: | |
|---|---|
| Ireland Recruitment Target: |